HOME >> BIOLOGY >> NEWS
Einstein's Susan Band Horwitz, PhD wins Bristol-Myers Squibb Cancer Research Award

BRONX, N.Y. Susan Band Horwitz, Ph.D., the Falkenstein Professor of Cancer Research and co-chair of the Department of Molecular Pharmacology at the Albert Einstein College of Medicine of Yeshiva University in New York, has been selected to receive the 29th annual Bristol-Myers Squibb Freedom to Discover Award for Distinguished Achievement in Cancer Research. She was recognized for her pioneering work over many decades in developing an understanding of the mechanisms of action of anti-tumor agents, especially complex natural products, as well as the mechanisms at the molecular level that cause resistance to these compounds. Her pivotal research in the 1980's eventually led to the development of paclitaxel (Taxol), one of the most important anti-cancer agents ever developed.

Dr. Horwitz was selected to receive the Distinguished Achievement Award by an independent panel of her peers, in a process in which Bristol-Myers Squibb takes no active role. The Award is a $50,000 cash prize and a silver commemorative medallion. Eighteen previous grant and award winners have also won Nobel Prizes.

While paclitaxel, found in the bark of the Pacific yew tree, was first identified in the early 1970's as a compound with a unique chemical structure and anti-tumor activity, it was not until Dr. Horwitz and her colleagues identified its singular mechanism of action for slowing tumor growth that the National Cancer Institute decided to undertake clinical trials, leading to its development and approval to treat a wide range of tumor types. Dr. Horwitz discovered that paclitaxel works by binding to microtubules, structures found in all cells and important in a wide range of cellular functions, including cell division. By stabilizing microtubules and thereby interfering with the normal functions of microtubules, paclitaxel in effect can halt or impede uncontrolled cancer cell growth. Today, paclitaxel remains widely used in the treatment of many types of pervasive tu
'"/>

Contact: Karen Gardner
kgardner@aecom.yu.edu
718-430-3101
Albert Einstein College of Medicine
26-Apr-2006


Page: 1 2 3

Related biology news :

1. Einsteins Dr. Vern Schramm elected to the National Academy of Sciences
2. Einsteins Dr. E. Richard Stanley receives 2006 E. Donnall Thomas Prize
3. Past AACR president Susan B. Horwitz elected to National Academy of Sciences
4. HSPHs Walter Willett wins Bristol-Myers Squibb/Mead Johnson Freedom to Discover Award
5. Journalists can register now for ECCO 14 -- the European Cancer Conference
6. Cancer cures could work for canines and humans
7. The Cancer Genome Atlas awards funds for technology development
8. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
9. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
10. Cancer stem cells can go it alone
11. Cancer drug enhances long-term memory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2019)... ... February 12, 2019 , ... Ava, a 115-pound Newfoundland, ... partially tore one of her cruciate ligaments. Just one year later, she suffered ... was able to recover without surgical intervention and resumed her normal activities without any ...
(Date:2/11/2019)... WASHINGTON (PRWEB) , ... February 11, 2019 , ... ... an Allotrope™ Data Model (ADM), completing the phased release of the Allotrope™ Framework ... new capability combines with the previously released Allotrope™ Data Format (ADF) and application ...
(Date:2/2/2019)... ... January 31, 2019 , ... Pharmica Consulting announced it will ... and focusing on all facets of clinical trial planning and management. Pharmica ... management, patient engagement, and more. , “We have attended the SCOPE Summit ...
Breaking Biology News(10 mins):
(Date:1/24/2019)... ... January 22, 2019 , ... Dr. Douglas Stramel of ... Pall Veterinary Platelet Enhancement Therapy System (V-PET™) for nearly three years. A ... Cell Therapy since 2007 and began using V-PET™ 2016. V-PET™ is a ...
(Date:1/20/2019)... ... January 17, 2019 , ... Consumers are directing healthcare ... of physicians. That's changing as many services now exist for patients to order ... market totaled $208 million in 2018, according to Kalorama Information’s new report, ...
(Date:1/15/2019)... ... January 15, 2019 , ... With the U.S. Congress designating January as Cervical Health ... testing service, today announces tips to help reduce the risk of Cervical Cancer. , ... Genital HPV is the #1 most common STD and an STI that almost ...
(Date:1/10/2019)... ... ... VGI Medical was founded in 2007 based on an invention developed by Tov ... VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc and CerLoc systems are specifically designed to ... to limit motion of the affected spinal segment. Applying the principles of this success, ...
Breaking Biology Technology:
Cached News: